HBS HEALTH WEST CONFERENCE

Date: September 20-21, 2007
Place: Hotel Sofitel San Francisco Bay                                 Directions

Abstract:Reserve your spot for the HBS Health West Conference now!! Get insights into the issues affecting your business, including life sciences, medical devices, diagnostics, healthcare delivery, venture capital, biopharmaceuticals, and more.

Enjoy the fine cuisine and superb meeting facilities of Sofitel San Francisco Bay Sofitel San Francisco Bay.

Network at a kick-off reception and dinner featuring David Ewing-Duncan, Chief Correspondent, "Biotech Nation" on National Public Radio, and Director, Center for Life Science Policy, UC Berkeley. His talk: Creative Disruptions: How to Thrive in the Coming Biorevolution.

Recharge in a day of stimulating, high-caliber sessions featuring:

Speakers:

Thomas B. Okarma, PhD, MD
Thomas Okarma served as Vice President of Research and Development, and Vice President of Cell Therapies before being named CEO of Geron. Previously, he was a senior Vice President at Rhone-Poulenc Rorer, which had acquired Applied Immune Sciences, Inc. (AIS), a company he founded and later served as Chairman and CEO. AIS was in advanced cell therapy human clinical trials in cancer and bone marrow transplantation and in early gene therapy human trials in breast cancer. Prior to founding AIS, he was a member of the faculty of the Stanford University School of Medicine. He received his AB from Dartmouth College, and his PhD and MD from Stanford University. He is the author of over 50 publications on cell and gene therapy and is an inventor on numerous patents in the field.

Gregory Lucier, MBA '90
Greg Lucier has served as Chief Executive Officer of Invitrogen and member of the board of directors since May 2003. In April 2004 he was appointed Chairman of the Board of Directors. Previously, he was the President and Chief Executive Officer of GE Medical Systems Information Technologies. He was named a corporate officer of GE in 1999 and served in a variety of leadership roles there, including Vice President Global Services, GE Medical Systems. He is Chairman of BIOCOM, and serves on the BIO Board of Directors as well as on the board of the Burnham Institute of Medical Research. He is actively involved at San Diego State as a distinguished lecturer. He received his BS in Engineering from Pennsylvania State University and an MBA from Harvard Business School.

Gabrielle LaJoie, MBA '98
Gabrielle Lajoie focuses on recruiting senior executives for clients in the pharmaceutical and life sciences industry. Based in San Francisco, she frequently works with venture capitalists to attract senior management to early stage, privately-held companies. Her clients also include public biotech and specialty pharmaceutical companies. Before joining Russell Reynolds Associates in 1999, she was a consultant with CSC Healthcare in New York. She began her career in the Boston office of Towers Perrin, the global management consultancy. She is a member of the Healthcare Businesswomen's Association, the Biotech Roundtable Organization and HBS Health. She received her BA in Psychology from the University of Vermont and her MBA from Harvard Business School.

Murray Aitken, MBA '87
Murray Aitken has been with IMS since July 2001 and has global responsibility for corporate strategy. He speaks regularly on the trends and outlook of the global biopharmaceutical market. Previously he had responsibility for the company's global consulting and services business. Prior to joining IMS, he was a partner with McKinsey & Company, based in the New Jersey office where he was part of the leadership of the pharmaceutical and medical devices practice. The early part of his McKinsey career was based in the Los Angeles and Seoul, Korea offices.